New Horizons – Real World Evidence in Action – Part 2
This video is of Rodrigo Salas of Fundación GIST México presenting Real World Evidence at New Horizons 2019 in Wayne, NJ.
This video is of Rodrigo Salas of Fundación GIST México presenting Real World Evidence at New Horizons 2019 in Wayne, NJ.
Real World Evidence in Action video presented by Piga Fernández, LRG Global Relations Coordinator, and Executive Director of Fundación GIST Chile, at New Horizons 2019.
PDF is available of LRG Science to print here. Real World Evidence in Action Although targeted medicine has brought about immense progress in cancer treatment, there are still enormous challenges [...]
Patient-provided, patient-focused data from the Patient Registry has been a core component of the LRG’s research model. Out of the foundation of real world data, we conducted a Side Effects Survey in the early [...]
Although targeted medicine has brought about immense progress in cancer treatment, there are still enormous challenges regarding patient survival. Randomized clinical trials (RCTs) driven by lab-based research have been the gold standard for identifying new [...]
On April 6th, 2018, Executive Director, Norman Scherzer; Data Analyst, Jerry Call; Real World Evidence Scientist, Yu Wang, and Patient Registry Director, Denisse Montoya, of The Life Raft Group, were invited to present at [...]
As part of the Life Raft Group’s continuing mission to be actively involved in improving the quality of healthcare for cancer patients, I attended the Clinical Trials Transformation Initiatives (CTTI) member meeting in Rockville, Maryland [...]
"Utilization of Real World Evidence Among Different Stakeholders" presented by Norman Scherzer at New Horizons 2017.
The Life Raft Group had the pleasure of hosting the global New Horizons GIST meeting this year in our Wayne, New Jersey office. This international meeting traditionally gathers global GIST advocates with the shared [...]
Patient-reported outcomes is a buzz-phase that we hear a lot these days. At the Life Raft Group, I was recently in a meeting where we were discussing patient-reported outcomes, the LRG registry and patient-powered [...]